The European Commission (EC) has approved Takeda's antibody-drug conjugate (ADC) Adcetris (brentuximab vedotin) plus the ...

The European Commission (EC) has approved Adcetris (brentuximab vedotin) in combination with etoposide, cyclophosphamide, ...

Australian comedian Magda Szubanski is set to undergo the Nordic Protocol, a rigorous chemotherapy regimen, after being ...

Osaka: Takeda has received approval from the European Commission (EC) for ADCETRIS (brentuximab vedotin) in combination with ...

Researchers from Mass General Brigham will present research discoveries and outcomes from clinical trials in cancer at the ...

The dual-targeting CAR T-cell therapy KITE-363 showed positive response rates and manageable side effects in relapsed or ...

The drug has been approved in combination with the chemotherapy regimen etoposide, cyclophosphamide, doxorubicin, dacarbazine ...

Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire industry chain, announced that Albipagrastim alfa for Injection (trade name: MAILISHENG, R&D code: 8MW0511) developed by ...

Diffuse Intrinsic Pontine Glioma DIPG is a rare and aggressive form of childhood brain cancer Scroll down to learn about this ...

The study evaluates symptom patterns in patients receiving immune checkpoint inhibitors—pembrolizumab (pembro), nivolumab (nivo), or combination nivo/ipilimumab (ipi)—across community oncology ...